Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Preface. Editorial Board. List of contributors. 1. Biochips beyond DNA: technologies and applications (J.H. Ng, L.L. Ilag). 2. Nonribosomal pept ide synthetases as technological platforms for the synthesis of highly m odified peptide bioeffectors - cyclosporin synthetase as a complex examp le (T. Velkov, A. Lawen). 3. Horseradish peroxidase: A valuable tool in biotechnology (A.M. Azevedo, V.C. Martins et al.). 4. Considera tions for the planning and conduct of reproducibility studies of in vitr o diagnostic tests for infectious agents (T. Derion). 5. Clinical trial methods to discover and validate predictive markers for treatment respon se in cancer (S. Paik).
6. Production of high-quality market ing applications: Strategies for biotechnology companies working with co ntract research organizations (S.J. Hecker, C. Preston, M. Foote). 7. Us e of benchmarking in the development of biopharmaceutical products (M. Giffin, S. McLeish). 8. The state of biopharmaceutical manufac turing (D.T. Molowa, R. Mazanet). 9. Review of current authorship guidel ines and the controversy regarding publication of clinical trial data (M
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Preface. Editorial Board. List of contributors. 1. Biochips beyond DNA: technologies and applications (J.H. Ng, L.L. Ilag). 2. Nonribosomal pept ide synthetases as technological platforms for the synthesis of highly m odified peptide bioeffectors - cyclosporin synthetase as a complex examp le (T. Velkov, A. Lawen). 3. Horseradish peroxidase: A valuable tool in biotechnology (A.M. Azevedo, V.C. Martins et al.). 4. Considera tions for the planning and conduct of reproducibility studies of in vitr o diagnostic tests for infectious agents (T. Derion). 5. Clinical trial methods to discover and validate predictive markers for treatment respon se in cancer (S. Paik).
6. Production of high-quality market ing applications: Strategies for biotechnology companies working with co ntract research organizations (S.J. Hecker, C. Preston, M. Foote). 7. Us e of benchmarking in the development of biopharmaceutical products (M. Giffin, S. McLeish). 8. The state of biopharmaceutical manufac turing (D.T. Molowa, R. Mazanet). 9. Review of current authorship guidel ines and the controversy regarding publication of clinical trial data (M